Proteomics in neuropathic pain research

Anesthesiology

Volumn 108, Issue 2, 2008, Pages 314-323

  Niederberger, Ellen ^a   Geisslinger, Gerd ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CHAPERONE; GALECTIN 3; HEAT SHOCK PROTEIN;

APOPTOSIS; CELL CYCLE; CELL FUNCTION; CELL METABOLISM; CLINICAL RESEARCH; EXCITOTOXICITY; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; NERVE COMPRESSION; NERVE CRUSH; NERVE DEGENERATION; NERVE INJURY; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PHOTOCHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; REVIEW; SCIATIC NERVE; SIGNAL PROCESSING; SPINAL CORD HEMISECTION; SPINAL CORD INJURY;

EID: 38549113398     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000299838.13368.6e     Document Type: Article

References (77)

1. Woolf CJ, Mannion RJ: Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet 1999; 353:1959-64
2. Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999; 83:389-400
3. Hansson PT, Dickenson AH: Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain 2005; 113:251-4
4. Chen H, Lamer TJ, Rho RH, Marshall KA, Sitzman BT, Ghazi SM, Brewer RP: Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc 2004; 79:1533-45
5. Kingery WS: A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997; 73:123-39
6. Koltzenburg M: Painful neuropathies. Curr Opin Neurol 1998; 11:515-21
7. Campbell JN, Meyer RA: Mechanisms of neuropathic pain. Neuron 2006; 52:77-92
8. Orth AP, Batalov S, Perrone M, Chanda SK: The promise of genomics to identify novel therapeutic targets. Expert Opin Ther Targets 2004; 8:587-96
9. Choudhary J, Grant SG: Proteomics in postgenomic neuroscience: The end of the beginning. Nat Neurosci 2004; 7:440-5
10. Gorg A, Weiss W, Dunn MJ: Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004; 4:3665-85
11. O'Farrell PH: High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250:4007-21
12. Matsumoto H, Komori N: Protein identification on two-dimensional gels archived nearly two decades ago by in-gel digestion and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Anal Biochem 1999; 270:176-9
13. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W: The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000; 21:1037-53
14. Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P: In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem 1992; 203:173-9
15. Burre J, Beckhaus T, Corvey C, Karas M, Zimmermann H, Volknandt W: Synaptic vesicle proteins under conditions of rest and activation: Analysis by 2-D difference gel electrophoresis. Electrophoresis 2006; 27:3488-96
16. Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ, Selby PJ: Proteomics: New perspectives, new biomedical opportunities. Lancet 2000; 356:1749-56
17. Engwegen JY, Gast MC, Schellens JH, Beijnen JH: Clinical proteomics: Searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci 2006; 27:251-9
18. Brehmer D, Godl K, Zech B, Wissing J, Daub H: Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors. Mol Cell Proteomics 2004; 3:490-500
19. Wang LX, Wang ZJ: Animal and cellular models of chronic pain. Adv Drug Deliv Rev 2003; 55:949-65
20. Greenberg J, McKeever PE, Balentine JD: Lysosomal activity in experimental spinal cord trauma: An ultrastructural cytochemical evaluation. Surg Neurol 1978; 9:361-4
21. Anderson TE: A controlled pneumatic technique for experimental spinal cord contusion. J Neurosci Methods 1982; 6:327-33
22. Tarlov IM: Acute spinal cord compression paralysis. J Neurosurg 1972; 36:10-20
23. Rivlin AS, Tator CH: Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 1978; 10:38-43
24. Watson BD, Prado R, Dietrich WD, Ginsberg MD, Green BA: Photochemically induced spinal cord injury in the rat. Brain Res 1986; 367:296-300
25. Hao JX, Xu XJ, Aldskogius H, Seiger A, Wiesenfeld-Hallin Z: Photochemically induced transient spinal ischemia induces behavioral hypersensitivity to mechanical and cold stimuli, but not to noxious-heat stimuli, in the rat. Exp Neurol 1992; 118:187-94
26. Gorman AL, Yu CG, Ruenes GR, Daniels L, Yezierski RP: Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury. J Pain 2001; 2:229-40
27. Wilcox GL: Pharmacological studies of grooming and scratching behavior elicited by spinal substance P and excitatory amino acids. Ann N Y Acad Sci 1988; 525:228-36
28. Christensen MD, Hulsebosch CE: Chronic central pain after spinal cord injury. J Neurotrauma 1997; 14:517-37
29. Christensen MD, Everhart AW, Pickelman JT, Hulsebosch CE: Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain 1996; 68:97-107
30. Bennett AD, Chastain KM, Hulsebosch CE: Alleviation of mechanical and thermal allodynia by CGRP(8-37) in a rodent model of chronic central pain. Pain 2000; 86:163-75
31. Ding Q, Wu Z, Guo Y, Zhao C, Jia Y, Kong F, Chen B, Wang H, Xiong S, Que H, Jing S, Liu S: Proteome analysis of up-regulated proteins in the rat spinal cord induced by transection injury. Proteomics 2006; 6:505-18
32. Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50:355-63
33. Choi Y, Yoon YW, Na HS, Kim SH, Chung JM: Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 1994; 59:369-76
34. Seltzer Z, Dubner R, Shir Y: A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990; 43:205-18
35. Tahmoush AJ: Causalgia: Redefinition as a clinical pain syndrome. Pain 1981; 10:187-97
36. Bennett GJ, Xie YK: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33:87-107
37. George A, Marziniak M, Schafers M, Toyka KV, Sommer C: Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain 2000; 88:267-75
38. Zimmermann M: Pathobiology of neuropathic pain. Eur J Pharmacol 2001; 429:23-37
39. Mochizucki D: Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol 2004; 19 (suppl 1):S15-9
40. Wagner R, Janjigian M, Myers RR: Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain 1998; 74:35-42
41. Jimenez CR, Stam FJ, Li KW, Gouwenberg Y, Hornshaw MP, De Winter F, Verhaagen J, Smit AB: Proteomics of the injured rat sciatic nerve reveals protein expression dynamics during regeneration. Mol Cell Proteomics 2005; 4:120-32
42. Bester H, Beggs S, Woolf CJ: Changes in tactile stimuli-induced behavior and c-Fos expression in the superficial dorsal horn and in parabrachial nuclei after sciatic nerve crush. J Comp Neurol 2000; 428:45-61
43. Decosterd I, Woolf CJ: Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain 2000; 87:149-58
44. Kim KJ, Yoon YW, Chung JM: Comparison of three rodent neuropathic pain models. Exp Brain Res 1997; 113:200-6
45. Lee DH, Chung K, Chung JM: Strain differences in adrenergic sensitivity of neuropathic pain behaviors in an experimental rat model. Neuroreport 1997; 8:3453-6
46. Kang SK, So HH, Moon YS, Kim CH: Proteomic analysis of injured spinal cord tissue proteins using 2-DE and MALDI-TOF MS. Proteomics 2006; 6:2797-812
47. Beattie MS, Farooqui AA, Bresnahan JC: Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma 2000; 17:915-25
48. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S: Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 2004; 15:415-36
49. Hagino S, Iseki K, Mori T, Zhang Y, Hikake T, Yokoya S, Takeuchi M, Hasimoto H, Kikuchi S, Wanaka A: Slit and glypican-1 mRNAs are coexpressed in the reactive astrocytes of the injured adult brain. Glia 2003; 42:130-8
50. Rasko JE, Klenova EM, Leon J, Filippova GN, Loukinov DI, Vatolin S, Robinson AF, Hu YJ, Ulmer J, Ward MD, Pugacheva EM, Neiman PE, Morse HC III, Collins SJ, Lobanenkov VV: Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF. Cancer Res 2001; 61:6002-7
51. Lee SC, Yoon TG, Yoo YI, Bang YJ, Kim HY, Jeoung DI, Kim HJ: Analysis of spinal cord proteome in the rats with mechanical allodynia after the spinal nerve injury. Biotechnol Lett 2003; 25:2071-8
52. Sullivan PG, Geiger JD, Mattson MP, Scheff SW: Dietary supplement creatine protects against traumatic brain injury. Ann Neurol 2000; 48:723-9
53. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF: Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 1999; 5:347-50
54. Xu CJ, Klunk WE, Kanfer JN, Xiong Q, Miller G, Pettegrew JW: Phosphocreatine-dependent glutamate uptake by synaptic vesicles: A comparison with ATP-dependent glutamate uptake. J Biol Chem 1996; 271:13435-40
55. Alzate O, Hussain SR, Goettl VM, Tewari AK, Madiai F, Stephens RL Jr, Hackshaw KV: Proteomic identification of brainstem cytosolic proteins in a neuropathic pain model. Brain Res Mol Brain Res 2004; 128:193-200
56. Komori N, Takemori N, Kim HK, Singh A, Hwang SH, Foreman RD, Chung K, Chung JM, Matsumoto H: Proteomics study of neuropathic and nonneuropathic dorsal root ganglia: Altered protein regulation following segmental spinal nerve ligation injury. Physiol Genomics 2007; 29:215-30
57. Arimura N, Menager C, Fukata Y, Kaibuchi K: Role of CRMP-2 in neuronal polarity. J Neurobiol 2004; 58:34-47
58. Katano T, Mabuchi T, Okuda-Ashitaka E, Inagaki N, Kinumi T, Ito S: Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia. Proteomics 2006; 6:6085-94
59. Kunz S, Tegeder I, Coste O, Marian C, Pfenninger A, Corvey C, Karas M, Geisslinger G, Niederberger E: Comparative proteomic analysis of the rat spinal cord in inflammatory and neuropathic pain models. Neurosci Lett 2005; 381:289-93
60. Gordh T, Chu H, Sharma HS: Spinal nerve lesion alters blood-spinal cord barrier function and activates astrocytes in the rat. Pain 2006; 124:211-21
61. Perlson E, Hanz S, Ben-Yaakov K, Segal-Ruder Y, Seger R, Fainzilber M: Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve. Neuron 2005; 45:715-26
62. Sharma HS, Gordh T, Wiklund L, Mohanty S, Sjoquist PO: Spinal cord injury induced heat shock protein expression is reduced by an antioxidant compound H-290/51: An experimental study using light and electron microscopy in the rat. J Neural Transm 2006; 113:521-36
63. Yenari MA, Giffard RG, Sapolsky RM, Steinberg GK: The neuroprotective potential of heat shock protein 70 (HSP70). Mol Med Today 1999; 5:525-31
64. Costigan M, Mannion RJ, Kendall G, Lewis SE, Campagna JA, Coggeshall RE, Meridith-Middleton J, Tate S, Woolf CJ: Heat shock protein 27: Developmental regulation and expression after peripheral nerve injury. J Neurosci 1998; 18:5891-900
65. Kretz A, Schmeer C, Tausch S, Isenmann S: Simvastatin promotes heat shock protein 27 expression and Akt activation in the rat retina and protects axotomized retinal ganglion cells in vivo. Neurobiol Dis 2006; 21:421-30
66. Latchman DS: HSP27 and cell survival in neurones. Int J Hyperthermia 2005; 21:393-402
67. Boyles JK, Notterpek LM, Anderson LJ: Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve: Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J Biol Chem 1990; 265:17805-15
68. Ignatius MJ, Gebicke-Harter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW, Shooter EM: Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A 1986; 83:1125-9
69. Tanaka S, Uehara T, Nomura Y: Up-regulation of protein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J Biol Chem 2000; 275:10388-93
70. Gruber CW, Cemazar M, Heras B, Martin JL, Craik DJ: Protein disulfide isomerase: The structure of oxidative folding. Trends Biochem Sci 2006; 31:455-64
71. Hinault MP, Ben-Zvi A, Goloubinoff P: Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging. J Mol Neurosci 2006; 30:249-65
72. Granville DJ, Gottlieb RA: The mitochondrial voltage-dependent anion channel (VDAC) as a therapeutic target for initiating cell death. Curr Med Chem 2003; 10:1527-33
73. Pesheva P, Kuklinski S, Schmitz B, Probstmeier R: Galectin-3 promotes neural cell adhesion and neurite growth. J Neurosci Res 1998; 54:639-54
74. Cameron AA, Dougherty PM, Garrison CJ, Willis WD, Carlton SM: The endogenous lectin RL-29 is transynaptically induced in dorsal horn neurons following peripheral neuropathy in the rat. Brain Res 1993; 620:64-71
75. Reichert F, Saada A, Rotshenker S: Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: Phagocytosis and the galactose-specific lectin MAC-2. J Neurosci 1994; 14:3231-45
76. Lubec G, Krapfenbauer K, Fountoulakis M: Proteomics in brain research: Potentials and limitations. Prog Neurobiol 2003; 69:193-211
77. Scholz J, Woolf CJ: Can we conquer pain? Nat Neurosci 2002; 5 (suppl):1062-7